Detection and Assessment of Case Clustering in Burkitt’s Lymphoma and Hodgkin’s Disease

  • A. G. Baikie
  • L. J. Kinlen
  • M. C. Pike
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 39)


Any joint consideration of Burkitt’s Lymphoma (BL) and Hodgkin’s Disease (HD) may, at first glance, seem unwarranted. HD was first described in 1832 and is of world-wide distribution; BL was first described only in the late 1950’s and its occurrence is geographically very restricted. BL occurs in children and has distinctive clinical features; HD occurs at all ages and its diagnosis depends on histological features which themselves may be the subject of debate. BL is a neoplasm of lymphocytes, while in HD the role of lymphocytes is uncertain and complex. Despite these differences the 2 neoplasms may be considered in parallel because of the increasing circumstantial evidence for viral aetiology in both. If they are caused by viruses they may show some of the epidemiological features of infectious diseases. Recognition of these features may not only help to identify the viruses responsible but is essential to understanding the diseases themselves. Case clustering is one of the features of infectious diseases, and it is this which is the subject of this paper.


Malignant Lymphoma Clinical Onset Diagnostic Error Sickle Cell Trait Time Cluster 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. ANDERSON, R. E., ISHIDA, K., Ii, Y., ISHIMARU, T., NISHIYAMA, H.: Geographic aspects of malignant lymphoma and multiple myeloma. Amer. J. Path. 61, 85 (1970).PubMedGoogle Scholar
  2. BLAISDELL, R. K., BOXER, G. J.: Ethnic comparisons of lymphomas in Hawaii: mortality rates for 1955 to 1968. Scientific Contributions, 2nd Meeting of the Asian-Pacific Division of the International Society of Haematology, Melbourne, 1971.Google Scholar
  3. BRUBAKER, G., GESER, A., PIKE, M. C.: Burkitt’s Lymphoma in the North Mara District of Tanzania. (In preparation) 1971.Google Scholar
  4. BURKITT, D. P., WRIGHT, D. H.: Burkitt’s Lymphoma. Edinburgh and London: Livingstone 1970.Google Scholar
  5. CLEMMESEN, J., BUSK, T., NIELSEN, A.: The topographical distribution of leukemia and Hodgkin’s Disease in Denmark, 1942–1946. Acta radiol. (Stockh.) 37, 223 (1952).CrossRefGoogle Scholar
  6. COLE, P., MACMAHON, B., AISENBERG, A.: Mortality from Hodgkin’s Disease in the United States. Lancet 1968 II, 1371.CrossRefGoogle Scholar
  7. COPPLESON, L. W., FACTOR, R. M., STRUM, S. B., GRAFF, P. W., RAPPAPORT, H.: Observer disagreement in the classification and histology of Hodgkin’s Disease. J. nat. Cancer Inst. 45, 731 (1970).PubMedGoogle Scholar
  8. CORREA, P., O’CONOR, G. T.: Epidemiologic patterns of Hodgkin’s Disease. Int. J. Cancer 8, 192 (1971).PubMedCrossRefGoogle Scholar
  9. CRIDLAND, M. D.: Seasonal incidence of clinical onset of Hodgkin’s Disease. Brit. med. J. 2, 621 (1961).PubMedCrossRefGoogle Scholar
  10. DE VORE, J. W., DOAN, C. A.: Studies in Hodgkin’s Syndrome, XII: Hereditary and epidemiologic aspects. Ann. int. Med. 47, 300 (1957).Google Scholar
  11. EISINGER, M., FOX, S. M., DE HARVEN, E., BIEDLER, J. L., SANDERS, F. K.: Virus-like agents from patients with Hodgkin’s Disease. Nature 233, 104 (1971).PubMedCrossRefGoogle Scholar
  12. FORBES, J. F., MORRIS, P. J.: Leucocyte antigens in Hodgkin’s Disease. Lancet 1970 II, 849.CrossRefGoogle Scholar
  13. FRAUMENI, J. F., LI, F. P.: Hodgkin’s Disease in childhood: an epidemiologic study. J. nat. Cancer Inst. 42, 681 (1969).PubMedGoogle Scholar
  14. GILMORE, H. R., ZELENSICK, G.: Environmental Hodgkin’s Disease and leukemia. Penn. med. J. 1047 (1962).Google Scholar
  15. INNES, J., NEWALL, J.: Seasonal incidence in clinical onset of Hodgkin’s Disease. Brit. med. J. 2, 765 (1961).CrossRefGoogle Scholar
  16. JACKSON, H. J., PARKER, F. J.: Hodgkin’s Disease and allied disorders. New York: Oxford University Press 1947.Google Scholar
  17. JOHANSSON, B., KLEIN, G., HENLE, W., HENLE, G.: Epstein-Barr Virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia, I. Hodgkin’s Disease. Int. J. Cancer 6, 450 (1970).PubMedCrossRefGoogle Scholar
  18. KAFUKO, G. W., MUNUBE, G. M. R., WILLIAMS, E. H., SMITH, P. G.: Burkitt’s Lymphoma in the West Nile District of Uganda, 1968–1970: Continued occurrence of time-space clustering.(In preparation) (1971).Google Scholar
  19. KNOX, E. G.: The detection of space-time interactions. Appl. Statistics 13, 25 (1964a).CrossRefGoogle Scholar
  20. KNOX, E. G.: Epidemiology of childhood leukaemia in Northumberland and Durham. Brit. J. prev.soc. Med. 18, 17 (1964b).Google Scholar
  21. LEVINE, P. H., O’CONOR, G. T., BERARD, C. W.: Antibodies to Epstein-Barr Virus (EBV) in American patients with Burkitt’s Lymphoma. (In preparation, 1971).Google Scholar
  22. MANTEL, N.: The detection of disease clustering and a generalised regression approach. Cancer Res. 27, 209 (1967).PubMedGoogle Scholar
  23. MAZAR, S. A., STRAUSS, B.: Marital Hodgkin’s Disease: a review of familial incidence and of etiological factors. Arch. int. Med. 88, 819 (1951).CrossRefGoogle Scholar
  24. MORROW, R. H., PIKE, M. C, SMITH, P. G., ZIEGLER, J. L., KISUULE, A.: Burkitt’s Lymphoma: a time-space cluster of cases in Bwamba County of Uganda. Brit. med. J. 2, 491 (1971).PubMedCrossRefGoogle Scholar
  25. ORDER, S. E., PORTER, M., HELLMAN, S.: Hodgkin’s Disease: evidence for a tumor-associated antigen. New Engl. J. Med. 285, 471 (1971).PubMedCrossRefGoogle Scholar
  26. PIKE, M. C, WILLIAMS, E. H., WRIGHT, B.: Burkitt’s tumour in the West Nile District of Uganda, 1961–1965. Brit. med. J. 2, 395 (1967).PubMedCrossRefGoogle Scholar
  27. PIKE, M. C, MORROW, R. H., KISUULE, A., MAFIGIRI, J.: Burkitt’s Lymphoma and sickle cell trait. Brit. J. prev. soc. Med. 24, 39 (1970).Google Scholar
  28. PIKE, M. C, SMITH, P. G.: Disease clustering: a generalisation of Knox’s approach to the detection of space-time interactions. Biometrics 24, 541 (1968).PubMedCrossRefGoogle Scholar
  29. RAZIS, D. V., DIAMOND, H. D., CRAVER, L. F.: Familial Hodgkin’s Disease: its significance and implications. Ann. int. Med. 51, 933 (1959).PubMedGoogle Scholar
  30. STERNBERG, C: (Cited by Jackson and Parker, 1947). Z. -heilk. 19, 12 (1897).Google Scholar
  31. SYMMERS, W. Sr. C.: Survey of the eventual diagnoses in 600 cases referred for a second histological opinion after an initial biopsy diagnosis of Hodgkin’s Disease. J. clin. Path. 21, 650 (1968).PubMedCrossRefGoogle Scholar
  32. WILLIAMS, E. H., SPIT, P., PIKE, M. C.: Further evidence of space-time clustering of Burkitt’s Lymphoma patients in the West Nile District of Uganda. Brit. J. Cancer 23, 235 (1969).PubMedCrossRefGoogle Scholar
  33. ZERVAS, J. D., DELAMORE, I. W., ISRAELS, M. C. G.: Leucocyte phenotypes in Hodgkin’s Disease. Lancet 1970 II, 634.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1972

Authors and Affiliations

  • A. G. Baikie
    • 1
  • L. J. Kinlen
    • 1
  • M. C. Pike
    • 1
  1. 1.Department of the Regius Professor of MedicineOxford UniversityOxfordGreat Britain

Personalised recommendations